Circulatory and vascular changes after aneurysmal subarachnoid hemorrhage

Journal of Neurosurgical Sciences

Volumn 55, Issue 4, 2011, Pages 329-341

  Wan, H ^a   Loch MacDonald, R ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Brain ischemia; Coronary vasospasm; Hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; CLAZOSENTAN; ENOXAPARIN; FASUDIL; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NIMODIPINE; OZAGREL; PIFITHRIN ALPHA; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; BRAIN ISCHEMIA; BRAIN VASOSPASM; CIRCULATION; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; HUMAN; INFLAMMATION; LEUKOCYTE; META ANALYSIS (TOPIC); MICROTHROMBUS; MICROVASCULATURE; NONHUMAN; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; SPREADING CORTICAL DEPRESSION; SUBARACHNOID HEMORRHAGE;

BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CORONARY VASOSPASM; HUMANS; SUBARACHNOID HEMORRHAGE;

EID: 84857586615     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40:994-1025.
2. Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998;50:1413-1418. (Pubitemid 28240362)
3. Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage. Population-based study and systematic review. Neurology 2010.
4. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009;8:635-642.
5. Macdonald RL. Management of cerebral vasospasm. Neurosurg Rev 2006;29:179-193.
6. Vergouwen MD, Vermeulen M, van GJ, Rinkel GJ, Wijdicks EF, Muizelaar JP et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010;41:2391-2395.
7. Dorsch N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir Suppl 2011;110:5-6.
8. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008;28:1761-1770.
9. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-3021.
10. Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011;42:919-923.
11. Dehdashti AR, Mermillod B, Rufenacht DA, Reverdin A, de TN. Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis 2004;17:53-60. (Pubitemid 38145908)
12. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35:1862-1866. (Pubitemid 38971866)
13. Lysakowski C, Walder B, Costanza MC, Tramer MR. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review. Stroke 2001;32:2292-2298. (Pubitemid 32954797)
14. Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011;42:924-929.
15. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991;22:971-982.
16. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004;101:255-261. (Pubitemid 38971001)
17. Osaka K. Prolonged vasospasm produced by the breakdown products of erythrocytes. J Neurosurg 1977;47:403-411. (Pubitemid 8170129)
18. Asano T, Matsui T. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage. [Review] [83 refs]. Cellular & Molecular Neurobiology 1999;19:31-44. (Pubitemid 29102092)
19. Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl 2008;104:139-147.
20. Sabri M, Ai J, Macdonald RL. Nitric oxide related pathophysiological changes following subarachnoid haemorrhage. Acta Neurochir Suppl 2011;110:105-109.
21. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsue Y et al. Endothelin: a novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415. (Pubitemid 18090241)
22. Fuwa I, Mayberg M, Gadjusek C, Harada T, Luo Z. Enhanced secretion of endothelin by endothelial cells in response to hemoglobin. Neurologia Medico-Chirurgica 1993;33:739-743. (Pubitemid 24000328)
23. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H et al. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 1997;87:287-293. (Pubitemid 27349116)
24. Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003;52:1188-1194.
25. Findlay JM, Weir BK, Kanamaru K, Espinosa F. Arterial wall changes in cerebral vasospasm. Neurosurgery 1989;25:736-745.
26. Vorkapic P, Bevan JA, Bevan RD. Longitudinal in vivo and in vitro time-course study of chronic cerebrovasospasm in the rabbit basilar artery. Neurosurgical Review 1991;14:215-219.
27. Zhang ZD, Macdonald RL. Contribution of the remodeling response to cerebral vasospasm. Neurol Res 2006;28:713-720. (Pubitemid 44656097)
28. Pluta RM, Zauner A, Morgan JK, Muraszko KM, Oldfield EH. Is vasospasm related to proliferative arteriopathy? J Neurosurg 1992;77:740-748.
29. Macdonald RL, Weir BK, Young JD, Grace MG. Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys. J Neurosurg 1992;76:81-90.
30. Chen D, Chen JJ, Yin Q, Guan JH, Liu YH. Role of ERK1/2 and vascular cell proliferation in cerebral vasospasm after experimental subarachnoid hemorrhage. Acta (Neurochir Wien) 2009;151:1127-1134.
31. Suzuki H, Hasegawa Y, Kanamaru K, Zhang JH. Mitogen-activated protein kinases in cerebral vasospasm after subarachnoid hemorrhage: a review. Acta Neurochir Suppl 2011;110:133-139.
32. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2011;31:1443-1451.
33. Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg 2010;73:654-667.
34. Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke 2009;40:3039-3044.
35. Dankbaar JW, Slooter AJ, Rinkel GJ, van der Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 2010;14:R23.
36. Treggiari MM. Hemodynamic Management of Subarachnoid Hemorrhage. Neurocrit Care 2011.
37. Zubkov YN, Nikiforov BM, SHUSTIN VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir 1984;70:65-79. (Pubitemid 14191588)
38. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 2005;16:501-16, vi. (Pubitemid 41766378)
39. Linfante I, gado-Mederos R, Andreone V, Gounis M, Hendricks L, Wakhloo AK. Angiographic and hemodynamic effect of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery 2008;63:1080-1086.
40. Wolf S, Martin H, Landscheidt JF, Rodiek SO, Schurer L, Lumenta CB. Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. Neurocrit Care 2010;12:346-351.
41. Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2008;108:458-463. (Pubitemid 351357976)
42. Schmidt U, Bittner E, Pivi S, Marota JJ. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone. Anesth Analg 2010;110:895-902.
43. Santillan A, Knopman J, Zink W, Patsalides A, Gobin YP. Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2011;69:95-102.
44. Frontera JA, Gowda A, Grilo C, Gordon E, Johnson D, Winn HR et al. Recurrent vasospasm after endovascular treatment in subarachnoid hemorrhage. Acta Neurochir Suppl 2011;110:117-122.
45. Wickman G, Lan C, Vollrath B. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm. Circ Res 2003;92:809-816. (Pubitemid 36457647)
46. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 1992;76:571-577.
47. Liu GJ, Wang ZJ, Wang YF, Xu LL, Wang XL, Liu Y et al. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol 2011.
48. Barker FG, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996;84:405-414. (Pubitemid 26062864)
49. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van GJ. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005,CD000277.
50. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998;50:876-883. (Pubitemid 28212809)
51. Dreier JP, Korner K, Ebert N, Gorner A, Rubin I, Back T et al. Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 1998;18:978-990. (Pubitemid 28427865)
52. Roos YB, Levi M, Carroll TA, Beenen LF, Vermeulen M. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001;32:1860-1862. (Pubitemid 32772220)
53. Nystoriak MA, O'Connor KP, Sonkusare SK, Brayden JE, Nelson MT, Wellman GC. Fundamental increase in pressure-dependent constriction of brain parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane depolarization. Am J Physiol Heart Circ Physiol 2011;300:H803-H812.
54. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002;33:1011-1015. (Pubitemid 34293584)
55. Weir B. Aneurysms Affecting the Nervous System. Baltimore: Williams & Wilkins; 1987.
56. Rowe JG, Soper N, Ouwerkerk R, Kerr RS, Radda GK, Rajagopalan B. Delayed ischaemia after subarachnoid haemorrhage: a role for small vessel changes (letter). J Neurol Neurosurg Psychiatr 1995;59:451-452.
57. Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1621-1627. (Pubitemid 30437513)
58. Herz DA, Baez S, Shulman K. Pial microcirculation in subarachnoid hemorrhage. Stroke 1975;6:417-424.
59. Sun BL, Zheng CB, Yang MF, Yuan H, Zhang SM, Wang LX. Dynamic alterations of cerebral pial microcirculation during experimental subarachnoid hemorrhage. Cell Mol Neurobiol 2009;29:235-241.
60. Ohkuma H, Suzuki S. Histological dissociation between intraand extraparenchymal portion of perforating small arteries after experimental subarachnoid hemorrhage in dogs. Acta Neuropathologica 1999;98:374-382. (Pubitemid 29440684)
61. Perkins E, Kimura H, Parent AD, Zhang JH. Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs. J Neurosurg 2002;97:896-904. (Pubitemid 35222413)
62. Yundt KD, Grubb RL, Jr., Diringer MN, Powers WJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab 1998;18:419-424. (Pubitemid 28166517)
63. Grubb RLJ, Raichle ME, Eichling JO, Gado MH. Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans. J Neurosurg 1977;46:446-453. (Pubitemid 8067470)
64. Hino A, Mizukawa N, Tenjin H, Imahori Y, Taketomo S, Yano I et al. Postoperative hemodynamic and metabolic changes in patients with subarachnoid hemorrhage. Stroke 1989;20:1504-1510. (Pubitemid 19278137)
65. Dankbaar JW, de Rooij NK, Smit EJ, Velthuis BK, Frijns CJ, Rinkel GJ et al. Changes in cerebral perfusion around the time of delayed cerebral ischemia in subarachnoid hemorrhage patients. Cerebrovasc Dis 2011;32:133-140.
66. Uhl E, Lehmberg J, Steiger HJ, Messmer K. Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery 2003;52:1307-1315.
67. Pennings FA, Bouma GJ, Ince C. Direct observation of the human cerebral microcirculation during aneurysm surgery reveals increased arteriolar contractility. Stroke 2004;35:1284-1288. (Pubitemid 38697444)
68. Pennings FA, Albrecht KW, Muizelaar JP, Schuurman PR, Bouma GJ. Abnormal responses of the human cerebral microcirculation to papaverin during aneurysm surgery. Stroke 2009;40:317-320.
69. LEAO AA. Spreading depression of activity in the cerebral cortex. Journal of Neurophysiology 1944;7:359-390.
70. LEAO AA. Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol 1947;10:409-414.
71. Dietz RM, Weiss JH, Shuttleworth CW Contributions of Ca2+ and Zn2+ to spreading depression-like events and neuronal injury. J Neurochem 2009;109 Suppl 1:145-152.
72. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009;132.1866-1881.
73. Dreier JP, Eben N, Priller J, Meqow D, Lindauer U, Klee R et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 2000;93:658-666. (Pubitemid 32799301)
74. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011;17:439-447.
75. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006;129:3224-3237. (Pubitemid 44871438)
76. Bosche B, Graf R, Ernestus RI, Dohmen C, Reithmeier T, Brinker G et al. Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex. Ann Neurol 2010;67:607-617.
77. Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab 2011;31:17-35.
78. Stein SC, Browne KD, Chen XH, Smith DH, Graham DI. Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery 2006;59:781-787. (Pubitemid 44579595)
79. Lad SP, Hegen H, Gupta G, Deisenhammer F, Steinberg GK. Proteomic Biomarker Discovery in Cerebrospinal Fluid for Cerebral Vasospasm Following Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis 2010.
80. Ikeda K, Asakura H, Futami K, Yamashita J. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. Neurosurgery 1997;41:344-349.
81. Vergouwen MD, Bakhtiari K, van GN, Vermeulen M, Roos YB, Meijers JC. Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009.
82. Suzuki S, Suzuki M, Iwabuchi T, Kamata Y. Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report. Neurosurgery 1983;13:199-203. (Pubitemid 13035820)
83. Suzuki S, Kimura M, Souma M, Ohkima H, Shimizu T, Iwabuchi T. Cerebral microthrombosis in symptomatic cerebral vasospasm-a quantitative histological study in autopsy cases. Neurologia Medico-Chirurgica 1990;30:309-316. (Pubitemid 20270142)
84. Romano JG, Forteza AM, Concha M, Koch S, Heros RC, Morcos JJ et al. Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage. Neurosurgery 2002;50:1026-1030.
85. Romano JG, Rabinstein AA, Arheart KL, Nathan S, Campo-Bustillo I, Koch S et al. Microemboli in aneurysmal subarachnoid hemorrhage. J Neuroimaging 2008;18:396-401.
86. Sehba FA, Friedrich V. Early micro vascular changes after subarachnoid hemorrhage. Acta Neurochir Suppl 2011;110:49-55.
87. Sehba FA, Mostafa G, Knopman J, Friedrich V, Jr., Bederson JB Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 2004;101:633-640. (Pubitemid 43186422)
88. Scholler K, Trinkl A, Klopotowski M, Thai SC, Plesnila N, Trabold R et al. Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res 2007;1142:237-246. (Pubitemid 46413192)
89. Sehba FA, Bederson JB. Nitric oxide in early brain injury after subarachnoid hemorrhage. Acta Neurochir Suppl 2011;110:99-103.
90. Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;CD006184.
91. van den Bergh WM, Algra A, Dorhout Mees SM, van KF, Dirven CM, van GJ et al. Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke 2006;37:2326-2330.
92. Ono H, Mizukami M, Kitamura K, Kikuchi H. Ticlopidine: quo vadis? Subarachnoid hemorrhage. Agents & Actions - Supplements 1984;15:259-272.
93. Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y et al. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurol Res 1989;11:79-88. (Pubitemid 19179131)
94. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S et al. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 2003;99:953-959. (Pubitemid 44717388)
95. Wurm G, Tomancok B, Nussbaumer K, Adelwohrer C, Holl K. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg 2004;106:97-103. (Pubitemid 38299271)
96. Cahill J, Calvert JW, Marcantonio S, Zhang JH. p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage. Neurosurgery 2007;60:531-545.
97. Meguro T, Chen B, Lancon J, Zhang JH. Oxyhemoglobin induces caspase-mediated cell death in cerebral endothelial cells. J Neurochem 2001;77:1128-1135. (Pubitemid 32467067)
98. Yan J, Chen C, Hu Q, Yang X, Lei J, Yang L et al. The role of p53 in brain edema after 24 h of experimental subarachnoid hemorrhage in a rat model. Exp Neurol 2008;214:37-46.
99. Yan J, Li L, Khatibi NH, Yang L, Wang K, Zhang W et al. Blood-brain barrier disruption following subarchnoid hemorrhage may be faciliated through PUMA induction of endothelial cell apoptosis from the endoplasmic reticulum. Exp Neurol 2011;230:240-247.
100. Cahill J, Calvert JW, Solaroglu I, Zhang JH. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke 2006;37:1868-1874. (Pubitemid 44297744)
101. Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998;89:559-567. (Pubitemid 28440924)
102. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003;53:123-133.
103. Vecchione C, Frati A, Di PA, Cifelli G, Carnevale D, Gentile MT et al. Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension 2009;54:150-156.
104. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M et al. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir 1998;140:943-951. (Pubitemid 28474664)
105. Schoch B, Regel JP, Wichert M, Gasser T, Volbracht L, Stolke D. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery 2007;60:828-836.
106. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S et al. Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000;31:2971-2975.
107. del Zoppo GJ. Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 2008;5 Suppl 1:S12-S21.
108. Vecil GG, Larsen PH, Corley SM, Herx LM, Besson A, Goodyer CG et al. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res 2000;61:212-224. (Pubitemid 30451809)
109. Kimura H, Gules I, Meguro T, Zhang JH. Cytotoxicity of cytokines in cerebral microvascular endothelial cell. Brain Res 2003;990:148-156. (Pubitemid 37244070)
110. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004;109:2698-2704. (Pubitemid 38737913)
111. Provencio JJ, Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol 2005;25:435-444.
112. Nozari A, Dilekoz E, Sukhotinsky I, Stein T, Eikermann-Haerter K, Liu C et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010;67:221-229.